The clinical course of IDH1/2-wildtype astrocytomas

Slični predmeti

• The clinical course of IDH1/2-wildtype astrocytomas
  od: N. Keric, i dr.
  Izdano: (2021-01-01)
• Socioeconomic Effects on Survival Outcome in IDH-wildtype Glioma Patients: Examining the Role of Age, Education, and Lifestyle Factors
  od: Dr. Matthias Demetz, i dr.
  Izdano: (2025-01-01)
• Regorafenib- A feasible option as third-line therapy of recurrent glioblastoma?
  od: Alice Dauth, i dr.
  Izdano: (2023-01-01)
• Interim analysis of the International IM4 Study: Clinical course of primary IDH-mutant astrocytoma CNS-WHO grade 4 and formerly known primary IDH-mutant glioblastoma WHO grade IV
  od: Dr. Harald Krenzlin, i dr.
  Izdano: (2025-01-01)
• Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas
  od: Aleksandrs Krigers, i dr.
  Izdano: (2021-08-01)